Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience

被引：10
|
作者：
Antonioli, Elisabetta [1 ]
Staderini, Michela [1 ]
Pilerci, Sofia [1 ]
Perfetto, Federico [2 ]
Cappelli, Francesco [2 ]
Allinovi, Marco [2 ,3 ]
Nozzoli, Chiara [4 ]
Attucci, Irene [1 ]
Buzzichelli, Alessandra [1 ]
Messeri, Maria [1 ]
Bosi, Alberto [1 ]
机构：
[1] Careggi Univ Hosp, Haematol Unit, Largo Brambilla 3, I-50134 Florence, Italy
[2] Careggi Univ Hosp, Tuscan Reg Amyloidosis Ctr, Florence, Italy
[3] Careggi Hosp, Nephrol Dialysis & Transplantat Unit, Florence, Italy
[4] Careggi Univ Hosp, Cell Therapy & Transfus Med Unit, Florence, Italy
来源：
LEUKEMIA & LYMPHOMA | 2020年 / 61卷 / 13期
关键词：
REFRACTORY MULTIPLE-MYELOMA; MONOTHERAPY;
D O I：
10.1080/10428194.2020.1802452
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3255 / 3258
页数：4
相关论文
共 50 条
  • [1] Carfilzomib, lenalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience
    Zherebtsova, Vera A.
    Vorobyev, Vladimir, I
    Gemdzhian, Eduard G.
    Ulyanova, Margarita A.
    Chernikov, Mikhail, V
    Ivanova, Valentina L.
    Vinogradova, Olga Yu
    Ptushkin, Vadim V.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (07) : 785 - 792
  • [2] "REAL-LIFE" EXPERIENCE OF CARFILZOMIB COMBINED WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS
    Antonioli, E.
    Staderini, M.
    Nozzoli, C.
    Guarrera, A. S.
    Messeri, M.
    Carrai, V.
    Puccini, B.
    Rigacci, L.
    Saccardi, R.
    Bosi, A.
    HAEMATOLOGICA, 2017, 102 : 131 - 132
  • [3] Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: a real-life experience
    Soyer, Nur
    Patir, Pusem
    Uysal, Ayse
    Duran, Mustafa
    Unal, Hatice Demet
    Durusoy, Raika
    Tombuloglu, Murat
    Sahin, Fahri
    Tobu, Mahmut
    Vural, Filiz
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 777 - 785
  • [4] Addition of daratumumab to the combination of lenalidomide and dexamethasone in relapsed or refractory myeloma
    Stocker, Nicolas
    HEMATOLOGIE, 2019, 25 (01): : 10 - 11
  • [5] Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience
    Canto, Chiara
    Ranucci, Elena
    Pulini, Stefano
    Santoleri, Fiorenzo
    Morelli, Anna Maria
    Fioritoni, Francesca
    Falorio, Simona
    Torti, Lorenza
    Spadano, Antonio
    D'Aloisio, Marianna
    Di Ianni, Mauro
    Santarone, Stella
    Di Bartolomeo, Paolo
    BLOOD, 2018, 132
  • [6] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SINGLE CENTRE REAL-LIFE EXPERIENCE
    Guidotti, F.
    Ferla, V
    Gregorini, A., I
    Rossi, F. G.
    Pompa, A.
    HAEMATOLOGICA, 2018, 103 : 38 - 38
  • [7] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Zacheo, I.
    Di Perna, M.
    Nappi, D.
    Pareto, A. E.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2017, 102 : 140 - 140
  • [8] A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH BELANTAMAB MAFODOTIN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Condorelli, A.
    Garibaldi, B.
    Gagliano, C.
    Romano, A.
    Ragusa, M.
    Del Fabro, V.
    Parrinello, N. L.
    Longo, A.
    Cosentino, S.
    Di Raimondo, F.
    Conticello, C.
    HAEMATOLOGICA, 2021, 106 (10) : 169 - 169
  • [9] A REAL LIFE SINGLE CENTER EXPERIENCE OF DARATUMUMAB, LENALDOMIDE AND DEXAMETHASONE COMBINATION IN MULTIPLE MYELOMA PATIENTS
    Attucci, I.
    Formica, G.
    Pilerci, S.
    Buzzichelli, A.
    Messeri, M.
    Vannucchi, A. M.
    Antonioli, E.
    HAEMATOLOGICA, 2021, 106 (10) : 165 - 165
  • [10] CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Ferrara, K.
    Peluso, I.
    Nappi, D.
    Di Perna, M.
    Zacheo, I.
    Pareto, A. E.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2017, 102 : 804 - 804
12345